
Lessons from Brandon Li, Power, democratizing access to clinical trials with marketplaces
Pear Healthcare Playbook
Three Reasons Why Multiple Sclerosis Trials Aren't Working
86% of clinical trials are delayed because they're trying to find patients on the other side of the table. The tools that exist today by and large, do not allow researchers to actually reach out to those patients. There's a lot of like noise being made over the last five, 10 years around big data analytics in EHR systems as well as insurance claims. That's what we're going to do.
00:00
Transcript
Play full episode
Remember Everything You Learn from Podcasts
Save insights instantly, chat with episodes, and build lasting knowledge - all powered by AI.